Combinations ; See Below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Cymevene | Roche | Roche Products | 500mg | 84 | Capsule | per capsule | KES 5,609.00 |
| Cymevene | Roche | Roche Products | 500mg | 10ml | Injection | per vial | KES 6,142.00 |
| Ganciclovir More info | |
|---|---|
| Mode Of Action | Inhibits viral DNA replication. |
| Drug Indication | cytomegalovirus (CMV) infection in immunocompromised patients |
| Contra-Indications | Life threatening cytomegalovirus infections in immunocompromised patients only. |
| Side Effects | Pronounced haematological disorders (mostly myelosuppression), fever, rashes, facial oedema, sore throat, epistaxis, malaise. |
| Dosage | 5mg/kg BD for 14-21 days by I.V oral over 1 hr. Maintenance dose: 5mg/kg daily. |
| Special Information | Guanosine analog that requires triphosphorylation for activation prior to inhibiting the viral DNA polymerase. |
| Pregnancy Category | Category C |
| Pregnancy Category Description | Drugs which, owing to their pharmacological effects, or may be suspected of causing detrimental effects on human foetus or neonates without causing malfunctions. These effects may be reversible |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Anti-Viral Drugs |